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Abstract
Ichthyoses are a heterogeneous group of inherited cornification disorders characterized by
generalized dry skin, scaling and/or hyperkeratosis. Ichthyosis vulgaris is the most common
form of ichthyosis in humans and caused by genetic variants in the FLG gene encoding filag-
grin. Filaggrin is a key player in the formation of the stratum corneum, the uppermost layer
of the epidermis and therefore crucial for barrier function. During terminal differentiation of
keratinocytes, the precursor profilaggrin is cleaved by several proteases into filaggrin mono-
mers and eventually processed into free amino acids contributing to the hydration of the cor-
nified layer. We studied a German Shepherd dog with a novel form of ichthyosis. Comparing
the genome sequence of the affected dog with 288 genomes from genetically diverse non-
affected dogs we identified a private heterozygous variant in the ASPRV1 gene encoding
“aspartic peptidase, retroviral-like 1”, which is also known as skin aspartic protease (SAS-
Pase). The variant was absent in both parents and therefore due to a de novo mutation
event. It was a missense variant, c.1052T>C, affecting a conserved residue close to an
autoprocessing cleavage site, p.(Leu351Pro). ASPRV1 encodes a retroviral-like protease
involved in profilaggrin-to-filaggrin processing. By immunofluorescence staining we showed
that the filaggrin expression pattern was altered in the affected dog. Thus, our findings pro-
vide strong evidence that the identified de novo variant is causative for the ichthyosis in the
affected dog and that ASPRV1 plays an essential role in skin barrier formation. ASPRV1 is
thus a novel candidate gene for unexplained human forms of ichthyoses.
Author summary
The skin undergoes a constant process of self-renewing and keratinocytes migrate from
the basal layer of the epidermis to the uppermost layer, the stratum corneum, as they dif-
ferentiate. A defect in the differentiation of keratinocytes can lead to cornification
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disorders such as ichthyosis. The most common form of this disorder in humans is
ichthyosis vulgaris caused by variants in the filaggrin gene. Filaggrin is required for bun-
dling intermediate filaments resulting in the flattening of keratinocytes. Filaggrin is pro-
duced from profilaggrin and the processing steps involve several enzymes including
proteases. In the present study, we sequenced the genome of a dog with a novel form of
ichthyosis. By comparing this sequence to 288 control genomes, we identified a private
missense variant in the ASPRV1 gene encoding the retroviral-like aspartic protease 1, also
known as SASPase, which is involved in the processing of profilaggrin. The variant was
due to a de novo mutation event, which is consistent with the patient being an isolated sin-
gle case of a novel form of ichthyosis. Filaggrin protein expression was altered in the skin
of the affected dog. Thus, our results strongly suggest that genetic variants in ASPRV1 can
cause ichthyosis by altering filaggrin processing.
Introduction
The skin and in particular the epidermis provide both an outward and inward barrier function,
which is essential for survival. Aberrant skin development or homeostasis can impair this bar-
rier function and may result in skin disorders. Ichthyoses are a heterogeneous group of skin
disorders characterized by dry skin, scaling and/or hyperkeratosis, often associated with ery-
throderma [1,2].These clinical signs are caused by a defect in the terminal differentiation of
keratinocytes and subsequent desquamation taking place in the uppermost layer of the epider-
mis, the stratum corneum. Ichthyoses are primarily inherited skin disorders that can either be
non-syndromic, when clinical findings are limited to the skin, or syndromic in case additional
organs are involved [2]. Non-syndromic forms of ichthyoses are further sub-classified into
common ichthyoses, autosomal recessive congenital ichthyoses, keratinopathic ichthyoses
caused by variants in different keratin genes, and other forms of ichthyoses [1,2].
The common ichthyoses consist of ichthyosis vulgaris (IV) and recessive X-linked ichthyosis
(RXLI). IV is the most common and mildest form of ichthyosis with an incidence of approxi-
mately 1:250 to 1:1000 in humans [2,3]. IV is caused by different semidominant genetic variants
in the FLG gene encoding filaggrin [4]. Filaggrin (filament aggregating protein) is a keratin bun-
dling protein and a key player in the formation of the stratum corneum [5]. The precursor of
filaggrin is the>400 kDa protein profilaggrin, which is the major component of keratohyalin
granules in the granular layer of the skin [6,7]. Profilaggrin consists of a unique N-terminus and
a series of filaggrin units separated by short linker peptides. The initially highly phosphorylated
profilaggrin is dephosphorylated and cleaved by proteases into individual filaggrin molecules
during the cornification process. In addition to its role in aggregating keratin intermediate fila-
ments into bundles, filaggrin is also degraded into free amino acids that contribute to the hydra-
tion of the cornified layer [8].
RXLI, sometimes also called X-linked ichthyosis (XLI), is clinically more severe and charac-
terized by dark brown scales and generalized dry skin. It is caused by variants, mainly large
deletions, affecting the STS gene, which encodes steroid sulfatase [9].
Autosomal recessive congenital ichthyoses (ARCI) are the second category of non-syndromic
ichthyoses. They may be caused by variants in at least 9 different genes: ABCA12,ALOX12B,
ALOXE3, CERS3,CYP4F22,LIPN, NIPAL4, PNPLA1 and TGM1 [2].
Finally, keratinopathic ichthyoses, the third category of non-syndromic ichthyoses, are
caused by variants in the KRT1, KRT2, or KRT10 genes [2]. Thus, there are currently 14 human
genes implicated in different forms of non-syndromic ichthyoses [2,10].
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Dogs represent valuable models for many human hereditary diseases and enabled for exam-
ple the discovery of PNPLA1 as an ichthyosis gene. The first pathogenic PNPLA1 variant was
identified in Golden Retriever ichthyosis, which is characterized by a mild phenotype. Interest-
ingly, this canine genodermatosis currently has an extremely high prevalence in the breed
[11,12]. Other dog models for human non-syndromic ichthyoses include Norfolk Terriers
with an epidermolytic ichthyosis caused by a KRT10 variant [13], Bulldogs with ARCI caused
by a NIPAL4 variant [14], and Jack Russell Terriers with another form of ARCI caused by a
TGM1 variant [15]. Further cases of canine ichthyoses have been reported, but the underlying
genetic defects have not been solved [16]. Thus, dogs might help to identify additional ichthyo-
sis genes, which might be of relevance for unsolved human forms of ichthyoses.
In the present study, we describe a novel non-epidermolytic form of ichthyosis in a German
Shepherd. In this breed, until now, no ichthyosis cases have been reported in the scientific lit-
erature. We therefore applied a whole genome sequencing approach to unravel the causative
genetic variant.
Results
Clinical and histopathological phenotype
An intact female German Shepherd was presented at 10 months of age with a history of severe
scaling of the skin with mild pruritus. According to the owner, the lesions started to develop
shortly after birth. Dermatological examination revealed generalized hypotrichosis and focal
areas of alopecia with generalized severe exfoliation of greyish scales and mild erythema. Com-
edones were seen on the ventral abdomen and in the perivulvar area (Fig 1).
The owner reported that this phenotype had not been seen in the six littermates or the
parents of the affected German Shepherd. The skin condition improved under topical treat-
ment with a rehydrating, anti-seborrheic spray and shampoo.
Histopathological analysis of four skin biopsies from different body regions revealed a
severe laminar to compact orthokeratotic hyperkeratosis extending into the follicular
Fig 1. Clinical phenotype of the affected German Shepherd. (A) Hypotrichosis and scaly skin. (B)
Alopecic region of the thigh with erythema and scales. (C) Comedones in the inguinal region. (D) Pinna with
scales and erythema.
doi:10.1371/journal.pgen.1006651.g001
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infundibula in all biopsies. The keratin layers were multifocally exfoliating as large scales. The
underlying epidermis was mildly hyperplastic. In the biopsy from the inguinal region, the
infundibula of the hair follicles were moderately dilated. The histological findings were consis-
tent with a cornification disorder and an inherited non-epidermolytic ichthyosis as possible
cause (Fig 2).
Genetic analysis
We sequenced the genome of the affected dog at 31x coverage and called SNVs and small indel
variants with respect to the reference genome (CanFam 3.1). We then compared these variants
to whole genome sequence data of 288 control dogs of various breeds including 13 German
Shepherds not closely related to the affected dog (Table 1). As we did not find any protein-
changing variants in the 14 known ichthyosis-associated genes, we hypothesized that the
affected dog represented an isolated case of a novel form of ichthyosis. Consequently, we con-
sidered both a recessive and a dominant mode of inheritance for the hypothetical mutant
allele.
As purebred dogs are maintained in closed populations with a small effective population
size and a considerable degree of inbreeding, recessive genetic defects within a breed typically
can be traced back to single founders and are mostly found in homozygous state in affected
Fig 2. Histopathological findings in skin of the ichthyotic dog and a control dog. (A) Skin of the
ichthyotic dog with severe laminar to compact orthokeratotic hyperkeratosis extending in the follicular
infundibula and covering a mildly hyperplastic epidermis. Hematoxylin and Eosin 40x. (B) Skin of a normal
dog with normal thickness of the epidermis covered by basket-weave orthokeratotic keratin. Hematoxylin and
Eosin 40x. (C,D) Skin sections of the same dogs as in A and B at higher magnification (100x).
doi:10.1371/journal.pgen.1006651.g002
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dogs. In a first analysis, assuming a recessive mode of inheritance, we therefore searched for
homozygous private protein-changing variants in the affected dog. Our automated pipeline
detected 4 such homozygous protein-changing variants. However, upon individual visual
inspection all 4 variants turned out to be sequencing artifacts. They were either located close to
gaps in the reference assembly, in highly repetitive sequences, or in regions with low read cov-
erage (S1 Table).
Given that the described dog was the only case in a litter of seven and ichthyosis had never
before been reported in the German Shepherd breed, we hypothesized that a dominant mode
of inheritance due to a de novo mutation event was more likely than a recessive mode of inheri-
tance. In a second analysis, we therefore filtered for heterozygous private protein-changing
variants. Our automated pipeline identified 19 such variants in 13 genes. None of the identified
variants was located in a known ichthyosis gene. In order to identify potential de novo variants,
we obtained whole genome sequences from both parents of the affected dogs. Inspection of the
sequencing data for each of the 19 heterozygous candidate variants revealed that only one of
them was indeed a de novo variant (S1 Table).
This de novo variant was a missense variant, c.1052T>C, located in the ASPRV1 gene
encoding “aspartic peptidase, retroviral-like 1” also known as skin aspartic protease (SASPase),
which is involved in profilaggrin-to-filaggrin processing [17,18,22]. We performed Sanger
sequencing in the affected dog and both parents and confirmed that the variant was absent in
both parents (Fig 3A). We experimentally confirmed the correct parentage by an analysis of
microsatellite and SNV genotypes in the trio.
The ASPRV1:c.1052T>C variant is predicted to result in the amino acid substitution
p.(Leu351Pro). The leucine at position 351 is strictly conserved among different species of
placental mammals and only one residue away from one of the major cleavage sites required
for auto-activation of the protein (Fig 3B) [17].
Functional confirmation
To assess the putative impact of the ASPRV1 missense variant we performed immunofluo-
rescence staining with anti-ASPRV1 antibodies on skin sections of the affected and a con-
trol dog. The ASPRV1 signal in the affected dog showed the expected localization, mainly in
the stratum granulosum, but was stronger than in the control dog (Fig 4). As this experi-
ment could not assess whether the detected ASPRV1 protein is functional, we also investi-
gated filaggrin processing by immunofluorescence staining with anti-filaggrin antibodies.
This experiment demonstrated an abnormal filaggrin expression pattern in the affected dog
(Fig 4). In the affected dog, diffuse staining across epidermal layers (from stratum basale
through stratum spinosum to stratum granulosum) and some nuclear staining indicated
defective processing of profilaggrin.
Table 1. Variants detected by whole genome re-sequencing of the affected dog.
Filtering stepa Number of variants
Homozygous variants in the whole genome 3,108,583
Private homozygous variants (absent from 288 control genomes) 797
Protein-changing private homozygous variants (absent from 288 control genomes) 4
Heterozygous variants in the whole genome 2,767,699
Private heterozygous variants (absent from 288 control genomes) 3,202
Protein-changing private heterozygous variants (absent from 288 control genomes) 19
a The sequences were compared to the reference genome (CanFam 3.1) from a Boxer.
doi:10.1371/journal.pgen.1006651.t001
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Discussion
In the present study we identified a de novo missense variant in the canine ASPRV1 gene in a
dog with a novel form of ichthyosis. We provide five arguments supporting the causality of the
ASPRV1:c1052T>C variant for the observed ichthyosis.
First, the c.1052T>C variant leads to a non-conservative amino acid exchange p.(Leu351Pro)
close to the functionally important auto-cleavage site of the ASPRV1 protease. It is thus conceiv-
able that this specific genetic variant might affect the protein function.
Second, the c.1052T>C was absent from 288 non-affected dogs of different breeds and thus
perfectly associated with the disease status.
Third, the affected dog was heterozygous for the variant, but the mutant allele was absent in
blood leukocytes of both parents. We therefore confirmed that the variant had arisen by a de
novo mutation event that must have occurred in either one of the parental germlines or during
early embryonic development of the affected dog. While exact numbers on the frequencies of
de novo mutation events in dogs were not available at the time of this study, an analysis of 10
human trios reported 73 de novo mutation events on average per trio [19]. In another study on
human de novo mutation events, it was shown that only ~1.3% of the de novo variants actually
represented protein-changing variants [20]. Similar numbers of de novo mutation events were
observed in cattle [21]. If we assume that these numbers are similar in dogs, one might expect
roughly one de novo protein-changing variant in any dog on average, which exactly matches
our data with one identified protein-changing variant in the affected dog. We deem it unlikely
that such an event would coincidentally affect a gene with a known role in filaggrin processing
without being causative for the ichthyosis phenotype.
Fourth, we observed a difference in the ASPRV1 protein expression between the affected
dog and a control dog. Somewhat surprisingly, the ASPRV1 protein expression was upregu-
lated in the affected dog. Such an upregulation might have been caused by a compensatory
Fig 3. Sanger electropherograms of the ASPRV1:c.1052T>C variant and evolutionary conservation of
leucine 351 in the ASPRV1 protein. (A) A genomic ASPRV1 fragment was amplified by PCR and sequenced
with the Sanger method. The figure shows genotypes of the affected daughter and both her non-affected parents.
The position of the variant is indicated by an arrow. Note that the variant C-allele is only present in the daughter,
but absent from both parents indicating a de novo mutation event. (B) The leucine residue at position 351 of the
canine ASPRV1 protein is strictly conserved in several species and located close to the C-terminal auto cleavage
site, which is indicated by arrowheads. The multiple alignment was done using accessions XP_013972931.1
(Canis lupus familiaris), NP_690005.2 (Homo sapiens), XP_525777.1 (Pan troglodytes), XP_014586589.1
(Equus caballus), XP_003586694.1 (Bos taurus), XP_003354829.2 (Sus scrofa), NP_080690.2 (Mus musculus)
and XP_008761336.1 (Rattus norwegicus). A full-length alignment of the proteins from selected species is given
in S1 Fig.
doi:10.1371/journal.pgen.1006651.g003
ASPRV1 variant in a dog with tchthyosis
PLOS Genetics | DOI:10.1371/journal.pgen.1006651 March 1, 2017 6 / 13
mechanism, if the expressed ASPRV1 protein is non-functional as has been reported for other
missense variants [22]. Thus, the increased ASPRV1 quantity is at least compatible with a
causal role of the ASPRV1 missense variant in the observed ichthyosis.
Finally and as fifth argument, we experimentally confirmed that the filaggrin protein
expression pattern was altered in the affected dog suggesting a defect in profilaggrin-to-filag-
grin processing. In our opinion and taken together, these arguments prove the causality of the
ASPRV1:c1052T>C variant for the observed ichthyosis beyond any reasonable doubt.
The ASPRV1 gene and its encoded protease were initially identified in humans and shortly
afterwards in mice. ASPRV1 protein expression was only detected in stratified epithelia and
was restricted to the stratum granulosum [17,18]. Further studies suggested that ASPRV1
cleaves the linker sequence in profilaggrin. A deficiency of ASPRV1 resulted in a lower level of
Fig 4. ASPRV1 and filaggrin protein expression. Skin sections of the case and a non-affected control dog were stained for immunofluorescence with
an anti-ASPRV1 or anti-filaggrin antibody, respectively. The ASPRV1 signal was stronger in the affected dog than in the control dog. The typical specific
expression pattern of filaggrin, a line at the border between stratum granulosum and stratum corneum, was observed in the control dog (bottom panels)
but not in the affected dog (third row of panels). Specificity of the antibodies was demonstrated by using rabbit IgG as primary antibody (last column).
Scale bars: 25 μm.
doi:10.1371/journal.pgen.1006651.g004
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stratum corneum hydration [23]. Furthermore, high ASPRV1 protein levels were present in
several non-neoplastic skin disorders [17,24].
In transgenic mice, aberrant Asprv1 expression resulted in delayed wound closure [25].
Asprv1 deficient mice (Asprv1-/-) in a C57BL/6J background showed characteristic parallel skin
wrinkles or lined grooves parallel to the body axis, but were reported to have normal skin his-
tology and did not show any signs of ichthyosis [18]. The skin of Asprv1-/- mice in a hairless
background (Hos:HR-1) displayed more fine wrinkles and was drier and rougher than in
Asprv1+/- or Asprv1+/+ mice [23]. In addition to an increased number of epidermal cell layers
and a lower level of stratum corneum hydration, a decreased amount of filaggrin monomers
together with an accumulation of aberrantly processed profilaggrin in the lower stratum cor-
neum was observed in these mice. The total amount and the composition of free amino acids
was however not significantly different from control mice [23].
Our results clearly showed an altered filaggrin expression pattern in the skin of an affected
dog with the ASPRV1 variant. Thus, similar to Asprv1 deficient mice, profilaggrin processing
appeared to be defective in the affected dog. In contrast to the findings by Matsui et al. [23], we
did however not detect an accumulation of incompletely processed filaggrin in the stratum
corneum, but rather in the stratum spinosum and stratum granulosum. It remains unclear
why the Asprv1-/- mice did not show an ichthyosis phenotype as the ASPRV1 mutant dog.
Potential explanations include a gain of function effect of the specific canine missense variant
or general differences in the homeostasis of the epidermis between mice and dogs.
According to our knowledge, the ASPRV1 gene has not been associated with any form of
ichthyosis in humans. Missense variants in the human ASPRV1 gene were reported in 5 of 196
Japanese patients with atopic eczema and 2 of 28 control subjects [23]. Two of the identified
variants, p.V243A (identified in a control subject) and p.V187I (identified in 3 atopic eczema
patients) led to absence or reduction of ASPRV1 activity in vitro [23]. Another study failed to
find significant associations between ASPRV1 genetic variants and atopic eczema or clinically
dry skin in different cohorts of Caucasian ancestry [26].
In conclusion, with the identification of a dominant de novo missense variant in the
ASPRV1 gene of an ichthyotic dog, we present a new candidate gene for ichthyosis. It seems
possible that ASPRV1 variants might also contribute to unsolved human ichthyoses.
Materials and methods
Ethics statement
All animal experiments were performed according to the local regulations. The dogs in this
study were examined with the consent of their owners. The study was approved by the “Can-
tonal Committee For Animal Experiments” (Canton of Bern; permits 22/07, 23/10, and 75/
16).
Clinical and histopathological examination
The affected dog was examined by a board certified veterinary dermatologist in a private spe-
cialist clinic and followed up after initiating treatment with a rehydrating, anti-seborrheic
spray (Ermidra, Ufamed AG, Sursee, Switzerland) and shampoo (Sebomild P, Virbac AG,
Glattbrugg, Switzerland).The absence of a similar phenotype in littermates, parents and ances-
tors was reported by the owner. Skin biopsies (6 mm) of the case were taken from the flank,
thigh, shoulder, and inguinal region and fixed in 10% buffered formalin for 24 hours. Biopsies
were processed, embedded in paraffin and sectioned at 4 μm. Skin sections were stained with
hematoxylin and eosin. The histopathology was performed by board certified pathologists.
ASPRV1 variant in a dog with tchthyosis
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DNA isolation and parentage confirmation
We isolated genomic DNA from EDTA blood samples of the affected dog and its parents. We
confirmed the parentage by two different approaches: A multiplex PCR with 7 fluorescently
labeled microsatellites primer pairs was performed for both parents and the case. Allele sizes
were determined on an ABI 3730 capillary sequencer (Life Technologies) and analyzed using
the GeneMapper software (Life Technologies). Mendelian transmission of the alleles was con-
firmed at all 7 loci. The three dogs were additionally genotyped for 173,662 SNVs on the illu-
mina canine_HD chip by GeneSeek/Neogen. We evaluated the parentage using the −−genome
and−−mendel commands in plink 1.07 [27]. Both analyses were in agreement with the
assumed parentage (<0.001% genome regions with IBD = 0 for mother and father; 26 Mendel
errors for the trio).
Whole genome sequencing of the affected German Shepherd and its
parents
Illumina PCR-free TruSeq fragment libraries with insert sizes of 350 bp—400 bp were
prepared. For the affected dog, 276 million 2 x 150 bp paired-end reads or 31x coverage
were obtained on a HiSeq3000 instrument. The parents were sequenced at 21x coverage.
The reads were mapped to the dog reference genome assembly CanFam3.1 and aligned
using Burrows-Wheeler Aligner (BWA) version 0.7.5a [28] with default settings. The
generated SAM file was converted to a BAM file and the reads were sorted using samtools
[29]. Picard tools (http://sourceforge.net/projects/picard/) was used to mark PCR dupli-
cates. To perform local realignments and to produce a cleaned BAM file, we used the
Genome Analysis Tool Kit (GATK version 2.4.9, 50) [30]. GATK was also used for base
quality recalibration with canine dbsnp data as training set. The sequence data were
deposited under the study accession PRJEB16012 at the European Nucleotide Archive.
The sample accessions are SAMEA4506895 for the case (DS043), SAMEA72802918 for
the sire (DS053) and SAMEA72802168 for the dam (DS051).
Variant calling
Putative SNVs were identified in each sample individually using GATK HaplotypeCaller in
gVCF mode, and subsequently genotyped per-chromosome and genotyped across all samples
simultaneously [31]. Filtering was performed using the variant filtration module of GATK. To
predict the functional effects of the called variants, SnpEFF [32] software together with the
ENSEMBL (version 80) annotation CanFam 3.1 was used. We additionally visually inspected
the short read alignments of the functional candidate genes ABCA12,ALOX12B, ALOXE3,
CERS3,CYP4F22, FLG, KRT1, KRT10, KRT2, LIPN, NIPAL4, PNPLA1, STS, and TGM1 in the
integrative genome viewer [33] to exclude any structural variants in these genes. We also
inspected the CLDN1 gene in the same manner. For variant filtering we used 288 control
genomes, which were either publicly available [34] or produced during other projects of our
group. A detailed list of these control genomes is given in S2 Table.
Gene analysis
We used the dog CanFam 3.1 reference genome assembly for all analyses. Numbering
within the canine ASPRV1 gene corresponds to the accessions XM_014117456.1 (mRNA)
and XP_013972931.1 (protein). Numbering within the human ASPRV1 gene corresponds to
the accessions NM_152792.2 (mRNA) and NP_690005.2 (protein).
ASPRV1 variant in a dog with tchthyosis
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Sanger sequencing
We used Sanger sequencing to confirm the candidate variant c.1052T>C in ASPRV1 in the
affected dog and its absence in both parents. A 370 bp fragment containing the variant was
PCR amplified from genomic DNA using AmpliTaq Gold 360 Master Mix (Life Technologies)
and the primers ACCCCAGGGACAGATTAAGG and AGCTGAAGCTGAAGGCAGAG.
After treatment with shrimp alkaline phosphatase and endonuclease I, PCR products were
directly sequenced on an ABI 3730 capillary sequencer (Life Technologies). We analyzed the
Sanger sequence data using the software Sequencher 5.1 (GeneCodes).
Immunofluorescence staining and fluorescence microscopy
Immunofluorescence staining was performed on formalin-fixed paraffin-embedded skin
sections of an age- and sex-matched control dog and the affected dog with some adaptations
as described previously [35]. Briefly, tissue sections were deparaffinized using xylene. For
ASPRV1 staining, antigens were retrieved in a microwave oven for 20 min at 95˚C in sodium
citrate buffer (10 mM sodium citrate, pH 6.0). Blocking was performed for 1.5 hours at room
temperature (10% goat serum, 1% BSA, 0.1% Triton X-100; 5% cold fish gelatin in PBS). Tissue
sections were incubated with a polyclonal rabbit anti-ASPRV1 antibody (1:250, NBP2-33981,
Novus Biological) overnight at 4˚C and with the secondary goat anti-rabbit Alexa Fluor
488 nm antibody (1:1000, Abcam) for 1 hour at room temperature. DNA was stained with
4’,6-diamidino-2-phenylindole (DAPI) contained in Vectashield Antifade Mounting Medium
(Vector Laboratories). For filaggrin staining, antigens were retrieved in a pressure cooker for
15 min in Tris buffer (100 mM) with 5% urea. Blocking was performed for 1.5 hours at room
temperature (10% goat serum, 1% BSA, 0.1% Triton X-100; 5% cold fish gelatin in PBS). Tissue
sections were incubated with a polyclonal rabbit anti-filaggrin antibody (1:250, PRB-417P-100,
Covance) overnight at 4˚C and with the secondary goat anti-rabbit Alexa Fluor 488 nm anti-
body (1:1000, Abcam) for 1 hour at room temperature. DNA was stained with DAPI (1:1000,
Sigma Aldrich). Tissue sections serving as negative controls were incubated with rabbit IgG
serum. Images were taken with a Nikon Eclipse 80i fluorescence microscope using a Plan
Flour x40/10 oil-immersion objective and excitation wavelength of 393 and 488nm. Pictures
were captured and further processed using Improvision Open Lab 5.5.2. software.
Supporting information
S1 Fig. ASPRV1 protein alignment.
(PDF)
S1 Table. Private protein-changing variants in the affected dog.
(XLSX)
S2 Table. Control dogs used for whole genome sequencing.
(XLSX)
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